Position in ABBV
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$3,812,094
+$615,209 QoQ
Shares Held
15,149
+3.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.11%
of 13F equity value
Holder Rank
#1,486
of 4,153 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DeDora Capital, Inc. holds $14,607,227 across 7 Drug Manufacturers - General names. ABBV ranks #2 (26.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,644 | $4,370,723 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
15,149 | $3,812,094 | |
| 3 | AMGN |
Amgen Inc
|
7,475 | $2,706,847 | |
| 4 | JNJ |
Johnson & Johnson
|
6,554 | $1,664,519 | |
| 5 | MRK |
Merck & Co., Inc.
|
9,956 | $1,279,346 | |
| 6 | AZN |
Astrazeneca PLC
|
2,226 | $422,094 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,783 | $351,604 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,812,094 | 15,149 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $3,196,885 | 14,699 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $3,394,447 | 14,856 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $3,531,911 | 15,254 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $2,923,329 | 15,749 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $3,333,672 | 15,911 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $2,863,990 | 16,117 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $3,195,226 | 16,180 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $2,785,656 | 16,241 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $2,905,951 | 15,958 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $2,809,916 | 18,132 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $2,803,222 | 18,806 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $2,412,744 | 17,908 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $2,746,104 | 17,231 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $2,525,641 | 15,628 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $2,092,333 | 15,590 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $2,377,349 | 15,522 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $2,684,541 | 16,560 | Shares | Sole | 2022-04-14 | |
| 2021-09-30 | $1,794,525 | 16,636 | Shares | Sole | 2021-10-18 | |
| 2021-06-30 | $1,857,884 | 16,494 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $1,756,843 | 16,234 | Shares | Sole | 2021-04-27 | |
| 2020-12-31 | $1,883,911 | 17,582 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $1,691,362 | 19,310 | Shares | Sole | 2020-10-20 | |
| 2020-06-30 | $1,583,054 | 16,124 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $1,171,497 | 15,376 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||